Health ❯ Public Health ❯ Obesity

Weight Management

GLP-1 Drugs Medications Weight-loss Drugs Pharmaceuticals Weight Loss Drugs Medication Use Healthcare Services GLP-1 Medications Injection Therapies Anti-Obesity Medications

GLP-1 Drugs Linked to Lower Migraine Drug Use in Women, Fewer Asthma Flares in Danish Data

Researchers urge randomized trials to confirm any benefits beyond weight loss.

Global Analysis Shows Obesity Slowing in Wealthy Nations and Accelerating Elsewhere

Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase 2 as Phase 3 Nears

Trump Cites 'Very Fat' Friend's Ozempic Story to Decry Price Gap

Lilly’s Daily Obesity Pill Sustains Weight Loss After Switch From Wegovy or Zepbound

U.S. Obesity Rate Drops to 37% as GLP-1 Use Surges, Gallup Finds

Mounjaro Climbs to No. 2 in India by Sales as Wales Maps NHS Path for Weight‑Loss Drugs

GLP-1 Debate Intensifies: Australia Considers Subsidies as India Warns of Misuse Risks

UK and Eli Lilly Unveil £85m Pilot for Pharmacy and Digital Delivery of Weight-Loss Injections

Ultra-Processed Foods Slash Weight Loss and Fuel Cravings, Study Shows

UK Launches NHS 10-Year Plan to Expand Free Weight-Loss Injections

Turkey's Public BMI Campaign Draws Privacy and Dignity Concerns

Eli Lilly Launches Mounjaro in India to Address Obesity and Diabetes

U.S. Obesity Rates Decline for First Time in Over a Decade

UK Government Trials Weight-Loss Jabs to Tackle Unemployment

U.S. Obesity Rates Decline as Weight-Loss Drugs Gain Popularity